Clinical Trial Update: A Research Study on How Well Different Doses of the Medicine UBT251 Help People Living With Overweight or Obesity [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating different doses of UBT251 for overweight and obesity is currently recruiting, sponsored by Novo Nordisk A/S.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity
• Overweight

Drugs mentioned

• UBT251

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Overweight, Obesity | Phase 2 | Status: RECRUITING